Lyme Disease Practice and Research

Investigator Education

Where	Years	Education
Investigator Education University of Minnesota, College	1972	B.A. Chemistry
University of Minnesota, Medical School	1981	M.D. Medicine
Beth Israel Medical Center, Manhattan, NY	1982	Internship
University of Minnesota, School of Public Health	1983	M.P.H. Epidemiology
Beth Israel Medical Center, Manhattan, NY	1985	Residency
Mt. Sinai, Preventive and Community Medicine	1985	Residency

Work Experience

Position	Years
Work Physician, 175 Main Street, Mt. Kisco	1987 - Present
Attending, Northern Westchester Hospital	1987- Present
Principal Investigator, Clinical Trials, Mt. Kisco	1990 - Present
Assistant Professor of Medicine, Geriatric Department	1985 - 1987
Geriatrician, Veterans Hospital, Montrose	1985 - 1987
Director, Dementia Unit	1985-1987
Consulting Geriatrician, Coller Memorial Hospital	1985-1987
Physician, Cancer Detection Center	1981-1982
Teaching Assistant, Physics Department	1973-1975

Clinical Trial Expertise

Where	Years	Research Study
Glaxo	1988	Lyme Disease
Ciba-Geigy	1988	Hypertension
Eli Lilly	1988	Hypertension
Squibb	1988-1989	Acute Bronchitis
G.D. Searle	1988-1989	Generalized Anxiety
Eli Lilly	1988-1989	Analgesic (phase I, II)
UpJohn	1989	Streptococcal Pharyngitis; Uncomplicated Urinary Tract Infection; Wound and Soft Tissue Infection
Lyme Disease Practice and Research	1997-2000	Lyme Disease Surveillance Database
Pfizer	2002-2003	Gemini study Clinical Utility study for Cholesterol and Hypertension Phase IIIb Open labeled, multicenter trial
Columbia	2001-Present	Subinvestigator NIH sponsered trial - Columbia
Lyme Disease Practice and Research	1997-Present	Lyme Disease Retreatment Study
Lyme Disease Practice and Research	2003-present	Validation of Lyme treatment (VOLT)
Merck	2003	Migraine Therapy Evaluation Protocol Muli-center, open-label, crossover study comparing Maxalt with usual care oral migraine medication
Genzyme	2004	REACH Program An International Prosopective Observational Observational Registry in Subjects at Risk Of Atherosthrombotic Events
Watson	2004	MATRIX Trial Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin TDS